We only use cookies that are necessary for this site to function to provide you with the best experience. The controller of this site may choose to place supplementary cookies to support additional functionality such as support analytics, and has an obligation to disclose these cookies. Learn more in our Cookie Statement.
Nausea & Vomiting | Small Cell Lung Cancer | Food Safety Video, 07/02/2024
National Cancer Institute sent this bulletin at 07/02/2024 09:48 AM EDT
Nausea and vomiting may be side effects of cancer treatment and symptoms of some cancers. This new page explains what causes nausea and vomiting and how you can get relief.
The immunotherapy drug durvalumab (Imfinzi) can help people with early-stage small cell lung cancer live longer, results from a large clinical trial show. Durvalumab is a type of immunotherapy called an immune checkpoint inhibitor.
Some cancer treatments make it easier for you to get sick from contaminated food. This video shares eight tips that can help you properly handle and prepare food to reduce your risk of foodborne illness.
This updated page explains the types of surgery that are used to reduce the risk of breast cancer in people who are at very high risk. It also describes those most likely to benefit from surgery, potential harms of the surgeries, and ways to reduce risk that don’t involve surgery.
Lymphedema is swelling caused by a buildup of lymph fluid in the body between the skin and muscle. This new page explains symptoms to watch for and ways you can manage.
NCI researchers have developed a non-chemotherapy treatment regimen for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. More than half of clinical trial participants treated with the regimen, called ViPOR, saw their tumors shrink, including some who had full remissions.